Purpose The purpose of this study is to identify papers that have produced the most significant impact on research on strategic alliances in the biotechnology industry. The authors attempt to illustrate the thematic evolution of its intellectual structure through 616 papers published between...

Today, the EU is at the heart of scientific research and innovation in new, bio-based manufacturing solutions that will bolster the industrial competitiveness and sustainability of our economies. Biotechnology has the potential to improve our quality of life through a range of breakthrough...

This briefing identifies bio-based innovations with high potential to support the forthcoming updated EU bioeconomy strategy. The briefing also relates to broader EU climate and biodiversity goals, helping inform national and regional strategies. The analysis draws on data from EU and...

This paper examines the effects of data privacy regulation on R&D investment in the pharmaceutical and biotechnology sectors. In these industries, access to personal health data is essential for innovation, particularly in clinical research. Leveraging a firm-level panel of the world's top R&D...

Purpose: This study evaluates the success metrics of post-merger and acquisition (M&A) activities in the German biopharmaceutical industry, focusing on small- and medium-sized enterprises (SMEs). It examines how metrics such as economies of scale, economies of scope, market share, clinical...

Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and...

This report presents a patent landscape analysis investigating the innovation trends within the industrial biotechnology (IB) sector from 2015 to 2020. The study's primary objective is to identify the geographical hotspots of innovation, the key players, and the role of different types of...

DNA carries the genetic instructions that dictate how organisms develop and function - acting as a blueprint for life. By digging deeper into genetic differences and harnessing the power of gene editing, EU-funded researchers are opening up new possibilities in the medical and biotech fields....

Debt financing is important for financing major investments in the biopharmaceutical industry. Debt financing allows companies to raise funds without giving up ownership or control through indenture and covenants of the company. In this study, I analyze the effects of debt financing decisions on...

The bioeconomy is a growing sector in both high- and low-income countries, closely linked to innovation. However, knowledge creation and innovation flows remain underexplored due to their complexity. This study aims to introduce the Knowledge and Innovation System for the Bioeconomy (KISB) to...

The biopharmaceutical sector is of considerable interest during the COVID-19 pandemic. This study aims to investigate the biopharmaceutical sector using the Shenwan Industry Classification and provides insights into investment strategies. We combine factor and cluster analyses to reduce data...

This Communication aims to unlock the full benefits of biotechnologies and biomanufacturing, which are crucial for the competitiveness and modernisation of EU industry and offer high growth and productivity potential.

The study explores entrepreneurial ecosystems, which emphasize the impact of regional context on entrepreneurship, with a particular focus on the health sector. Given its innovation and knowledge intensity, coupled with industry-specific challenges, the health sector serves as an ideal case for...

This technical report focuses on innovation in biotechnologies (biotech), as captured by patented inventions worldwide. The study analyses international patents filed at multiple offices, at least two of which belonging to the IP5 consortium. Moreover, it relies on expert knowledge collected by...

The oil industry is responsible for production of many products in common use, such as plastic and fuel, which are used in various activities in modern society. However, the exploitation of these hydrocarbons has been considered aggressive to the environment and their reservoirs are not...

Research on how managers control R&D activities has tended to focus on the performance measurement systems used to exploit existing knowledge and capabilities. This focus has been at the expense of how broader forms of management control could be used to enable R&D contextual ambidexterity, the...

Corporate financial managers of biotech firms need long‐term financing to reach key milestones, and that requires a long‐ term capital structure. They must balance a mix of investors with different objectives and different investment horizons that includes traditional venture capitalists and...

Climate change has induced an ecological crisis necessitating reconsideration of how the law should manage human interactions with ecological systems. In most Western legal regimes, conservation policy has principally sought to advance historical or natural preservation or sustained yield...

Through a longitudinal study of the product development portfolios of 457 US-based firms in the biotechnology industry, we investigate how prolific inventors shape a firm’s innovative direction following product development failure. Contrary to received wisdom, we argue and demonstrate that an...

The link between entrepreneur's network centrality and innovation performance has been broadly studied in knowledge-intensive industries such as biotechnology. However, little research has been focused on the social mechanisms that allow innovators to reach such a central position. We contribute...

Apart from the basic statutory definition in section 65 of the Intellectual Property Act of Sri Lanka, there do not appear to be any detailed statutory guidelines or judicial decisions to provide any framework for the assessment of inventive step in Sri Lanka. The current statutory definition is...

Objective: The article aims to verify the development of innovation cooperation in the biopharmaceutical (biotech, pharma) industry in Central and Eastern Europe (CEE) taking into account the directions of innovation cooperation. I will try to verify the importance of location in innovation...

The continued impact of COVID-19 in the biotechnology sector is distinct from other industries, putting an additional strain on biotech employees. Like frontline workers, employees in biotechnology encounter circumstances where their performance is measured by life and death outcomes. Research...

Biological drugs account for just two percent of prescriptions filled in the U.S. but fifty percent of prescription-drug spending. To explore the role patents play in explaining high biologics prices, we build the first comprehensive database of patents associated with all FDA-approved...

"Providing a comprehensive account of the latest research and thinking on the bioeconomy, Davide Viaggi brings together expert authors to reflect on the economics of using renewable biological resources to produce bio-based materials, food, energy and more, through a wide set of technological...

The cross-cutting perspective of bioeconomy guides the transition away from non-renewable resources and towards biological resources,including the use of bio-based products, processes, and practices.Different countries and regions have quite different resource endowments and socio-economic...

With the increase in demand and need for sustainable biomass production, food and feed availability, and alternatives for renewable energy, the bioeconomy is at the centre of sustainable and circular economic development. For this reason, the supply side of the bioeconomy market needs...